Marisol Castillo-Castrejon

Dr. Marisol Castillo-Castrejon

University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
MCMarisol Castillo-Castrejon
Marisol Castillo-Castrejon
KYKyohei Yamaguchi
Kyohei Yamaguchi
RRRachel L. Rodel
Rachel L. Rodel
KEKathryn Erickson
Kathryn Erickson
AKAnita Kramer
Anita Kramer
TPTheresa L. Powell
Theresa L. Powell

1 October 2019 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
MCMarisol Castillo-Castrejon
Marisol Castillo-Castrejon
TJThomas Jansson
Thomas Jansson
TPTheresa L. Powell
Theresa L. Powell
Pregnancies complicated by obesity and/or gestational diabetes (GDM) are associated with peripheral insulin resistance, however the insulin responsiveness of the placenta in these pregnancy complications remains largely unknown. We tested the hypothesis that primary human trophoblast cells and placental villous explants will be insulin responsive characterized by amino acid transport, Akt and Erk activity with maternal obesity and/or GDM.We evaluated term placentas from women with normal body mass index (BMI) (NORMAL, n=15), obesity (OB, n=11), normal BMI with GDM (N-GDM, n=11) and obesity with GDM (OB-GDM, n=11). In a subgroup, primary human trophoblast cells (PHT) were isolated and in an independent subgroup placental villous explants were exposed to varying concentrations of insulin. Amino acid transport capacity and insulin signaling activity were determined. Insulin significantly increased amino acid transport activity to a similar degree in PHT cells isolated from NORMAL (+21%), N-GDM (+38%), OB (+37%) and OB-GDM (+35%) pregnancies. Insulin increased Akt and Erk phosphorylation in PHT cells (3-fold) and in villous explants (2-fold) in all groups to a similar degree.In contrast to the peripheral maternal insulin resistance commonly associated with obesity and/or GDM we found that the placenta is insulin sensitive in these pregnancy complications. We suggest that elevated maternal insulin levels in pregnancies complicated by obesity and/or GDM promote critical placental functions, including amino acid transport. Insulin-stimulated placental nutrient delivery may contribute to the increased risk of fetal overgrowth and adiposity in these pregnancies. Moreover, our findings may inform efforts to optimize insulin regimens for women with GDM.